The Quest to Cure Metastatic Non-Small Cell Lung Cancer With Immunotherapy
{{output}}
The introduction of immune checkpoint inhibitors targeting the programmed death-1 (PD-1) axis represented a major therapeutic advance, enabling long-term survival, and even cure, in a subset of patients, an outcome previously considered unattainable in metasta... ...